VON WILLEBRAND DISEASE AND ACQUIRED VON WILLEBRAND SYNDROME - A DIAGNOSTIC ALGORITHM

EHA Library, Maria Manuel Campos, 134654

DIAGNOSTIC CHALLENGES IN ACQUIRED VON WILLEBRAND DISEASE: A COMPLEX CASE OF PROSTATE CARCINOMA

EHA Library, Paul-Emile Claus, 134655

TAR SYNDROME - DIAGNOSTIC AND TREATMENT CASE REPORT

EHA Library, Violeta Grajqevci-Uka, 134656

PROPHYLAXIS IN RARE FACTOR DEFICIENCIES OF CHILDREN

EHA Library, Zafer Salcioglu, 134657

TWO IMPORTANT FACTORS WHICH AFFECT HEMOSTASIS IN HEMOPHILIA PAITENT WITH SURGERY

EHA Library, Shinyoung Hyun, 134658

INTERLEUKIN-27 RS153109 POLYMORPHISM AND THE RISK FOR ACQUIRED APLASTIC ANEMIA IN A CHINESE POPULATION

EHA Library, Meili Ge, 134659

THE DYSFUNCTION OF PLATELETS IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Rong Fu, 134660

IDENTIFICATION OF HAEMOSTASIS SYSTEM PATIENTS, SUFFERING FROM APLASTIC ANEMIA.

EHA Library, Vera Kobilyanskaya, 134661

ACQUIRED HLA-B*40:02 MUTATION LEADING TO FRAME SHIFT IN IDIOPATHIC APLASTIC ANEMIA

EHA Library, Jungwon Huh, 134662

HEMATOPOIESIS FEATURES OF APLASTIC ANEMIA PATIENTS WITH PNH CLONES

EHA Library, Natalya Semenova, 134663

COMPREHENSIVE LONG-TERM FOLLOW-UP OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A REPORT FROM A SINGLE CENTRE

EHA Library, Amparo Sempere, 134664

CLINICAL CHARACTERISTICS OF CHINESE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DIAGNOSED BY FLAER

EHA Library, Guangsheng He, 134665

PREVALENCE AND PATTERNS OF TREATMENT OF APLASTIC ANEMIA IN KOREA

EHA Library, Hawk Kim, 134666

APLASTIC ANEMIA IN CENTER TUNISIA

EHA Library, BECHIR ACHOUR, 134667

MONITORING OF SMALL PAROXYSMAL NOCTURNAL HEMOGLOBINURIA CLONE IN PATIENTS AFFECTED BY SEVERE APLASTIC ANEMIA OR APLASTIC ANEMIA

EHA Library, Raffaella Milani, 134668

RARE RECURRENT CHROMOSOMAL ABNORMALITIES IN CLL DETECTED BY CONVENTIONAL CYTOGENETICS AFTER STIMULATION WITH CPG-ODN & IL-2 AND FISH

EHA Library, Martina Stoklasova, 134669

OXIDATIVE STRESS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Giovanni D'Arena, 134670

THE ROLE OF CD38, CD23, CD200 AND CD43 EXPRESSION IN DISCRIMINATION OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA

EHA Library, Duygu Avcı, 134671

CD38 AND INTERLEUKIN 6 GENE POLYMORPHISM IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA- CORRELATION WITH CLINICAL AND LABORATORY PARAMETARS

EHA Library, Vojin Vukovic, 134672

THE EXPRESSION OF TOLL-LIKE RECEPTORS IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA.

EHA Library, Justyna Rybka, 134673

AGING AND PD-1 & PD-L1 GENE EXPRESSION: MARKERS OF IMMUNOSENESCENCE?

EHA Library, Dominique BRON, 134674

NEXT GENERATION SEQUENCING (NGS) ION TORRENT AMPLISEQ-TM TECHNOLOGY FOR THE IDENTIFICATION OF TP53 MUTATIONS ?SCREENING OF 39 CASES OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Laura De Stefano, 134675

GOLD NANOPARTICLES CONJUGATED WITH RITUXIMAB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ciprian Tomuleasa, 134676

THE ROLE OF TUMOR NECROSIS FACTOR (TNF) AND IT?S SOLUBLE RECEPTORS, STNFRI AND STNFRII, IN MYELOSUPRESSION DEVELOPING IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL)

EHA Library, Vira Barilka, 134677

IS CD200 EXPRESSION A SIGNIFICANT MARKER FOR DIFFERENTIATION OF B- LYMPHOPROLIFERATIVE DISEASES? IN A SINGLE TUBE ANALYSIS

EHA Library, Pelin Aytan, 134678

STRUCTURAL AND FUNCTIONAL ALTERATIONS OF THE COMPLEMENT SYSTEM IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Regina Michelis, 134679

BACH2 & PRDM1: PREDICTIVE MARKERS OF IMMUNOSENESCENCE IN AGING?

EHA Library, Dominique BRON, 134680

ALTERED SETMAR EXPRESSION ASSOCIATES WITH CLINICAL CHARACTERISTICSIN CHRONIC LYMPHOCYTIC LEUKEMIA.

EHA Library, Flavia Piazera, 134681

P-GLYCOPROTEIN TRANSPORT ACTIVITY UNDER REDOX BALANCE CHANGES IN LYMPHOCYTES OF PATIENTS WITH B-CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Yuliya Harmaza, 134682

IDENTIFICATION AND ROLE OF HUMAN REGULATORY B LYMPHOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Mohr Audrey, 134683

PRAME PROTEIN IS LOCATED IN EXTRACELLULAR SIDE OF MEMBRANE AND MIGHT BE A GOOD TARGET FOR ANTIBODY THERAPY OF HEMATOLOGICAL MALIGNANCIES

EHA Library, Natalya Lyzhko, 134684

CD49D AND CD26 ARE INDEPENDENT PROGNOSTIC MARKERS FOR DISEASEPROGRESSION IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, lamia Ibrahem, 134685

IMPORTANCE OF CD38 MARKER IN PROGNOSIS OF B CELL CHRONIC LYMPHOCYTIC LEUKEMIA (B-CLL) IN THE NEW ERA

EHA Library, Dusko Dukovski, 134686

IMPACT OF IGVH MUTATIONAL STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH ISOLATED GOOD AND INTERMEDIATE RISK GENETIC ABERRATIONS

EHA Library, Luis Miguel Juárez-Salcedo, 134687

REDISTRIBUTION PATTERN AND ASSESSMENT OF EARLY RESPONSE TO IBRUTINIB IN CLL BY TOTAL TUMOR MASS SCORE (TTM) - KROHEM CLL2 STUDY

EHA Library, Ozren Jaksic, 134688

A NEW PROGNOSTIC SCORING SYSTEM FOR TTFT FOR PATIENTS WITH CLL IN CHINA

EHA Library, Lay-Cheng Lim, 134689

AN ASSESSMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE ELIGIBLE FOR FIRST-LINE THERAPY BUT UNSUITABLE FOR FULL-DOSE FLUDARABINE.

EHA Library, Dusha Jeyakumaran, 134690

INSULIN-LIKE GROWTH FACTOR SYSTEM AS A PROGNOSTIC BIOMARKER IN CHRONIC LYMPHOCYTIC LEUKEMIA: A CROSS-SECTIONAL STUDY

EHA Library, Antigoni Lekka, 134691

SECONDARY MALIGNANCIES IN CHRONIC LYMPHOCYTIC LEUKEMIA: A SINGLE CENTRE RETROSPECTIVE ANALYSIS

EHA Library, Gianluigi Reda, 134692

COMPLEX ACTIVATION OF ANGIOGENIC SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FROM CIRCULATING ANGIOGENIC CYTOKINES.

EHA Library, Lukáš Smolej, 134693

FINAL RESULTS OF THE NCRI CLL210 TRIAL OF ALEMTUZUMAB, DEXAMETHASONE AND LENALIDOMIDE IN PATIENTS WITH HIGH-RISK CLL (ORIGINAL PROTOCOL)

EHA Library, Andrew Pettitt, 134694

SERUM RESISTIN IN RELATION TO B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA RISK AND ITS CORRELATIONS WITH PROGNOSTIC BIOMARKERS

EHA Library, Antigoni Lekka, 134695

CALRETICULIN GENE MUTATION IN HAIRY CELL LEUKEMIA AND RELATIONSHIP WITH PROGNOSIS

EHA Library, Salih Subari, 134696

FACTORS ASSOCIATED WITH TREATMENT CHOICE AND RESPONSE IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RE-TREATED WITH RITUXIMAB: THE OBSERVATIONAL PERLE STUDY

EHA Library, Driss Chaoui, 134697

PLATELET DYSFUNCTION CAUSED BY IBRUTINIB TREATMENT IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. MONOCENTRIC EXPERIENCE: CLINICAL AND LABORATORY CHARACTERIZATION.

EHA Library, Idanna Innocenti, 134698

EFFICACY OF IBRUTINIB-BASED THERAPY IN THE TREATMENT OF RECURRENT AND REFRACTORY FORMS OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Aleksei Kuvshinov, 134699

USE OF IBRUTINIB IN PATIENTS WITH B CELL LYMPHOID MALIGNANCIES: ADVERSE EVENTS AND MANAGEMENT IN COMMUNITY SETTING

EHA Library, Rajeev Ramakrishna, 134700

APPLYING PROBED CAPILLARY ISOELECTRIC FOCUSING (PROBED CIEF) FOR RESPONSE MONITORING OF SIGNAL INHIBITOR THERAPY DIRECTED AGAINST BRUTONS TYROSINE KINASE (BTK) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, John Burthem, 134701

IS C-REACTIVE PROTEIN A RELIABLE SURROGATE MARKER FOR INFECTION TO HELP FACILITATE DISCHARGE IN PATIENTS ON IBRUTINIB? (A SINGLE CENTRE EXPERIENCE)

EHA Library, David Sparksman, 134702

DYNAMICS OF BCR-ABL1 MULTIPLE MUTATION DETECTED BY SUBCLONING AND SEQUENCING IN TYROSINE KINASE INHIBITOR RESISTANT CML

EHA Library, Ki Hoon Kang, 134703

PPAR? IS A NOVEL THERAPEUTIC TARGETS IN PH-POSITIVE LEUKEMIA CELLS

EHA Library, Seiichi Okabe, 134704

PLASMA PROTEOMICS IN CHRONIC MYELOID LEUKEMIA PATIENTS BEFORE AND AFTER INITIATION OF TYROSINE KINASE INHIBITOR THERAPY REVEALS INDUCED TH1 IMMUNITY AND LOSS OF ANGIOGENIC STIMULI

EHA Library, Stina Söderlund, 134705

LEUKEMIC STEM CELLS DEFINED BY DIPEPTIDIL-PEPTIDASE IV (CD26) EXPRESSION IN CD34+CD38- STEM CELLS AND TYROSINE KINASE INHIBITOR THERAPY IN CHRONIC MYELOID LEUKEMIA

EHA Library, Paulo Rodrigues-Santos, 134706

MODULATION OF LEUKOTRIENE SIGNALING INHIBITING CELL GROWTH IN CHRONIC MYELOID LEUKEMIA

EHA Library, Elham Yektaei-Karin, 134707

ISODERIVATIVE PHILADELPHIA CHROMOSOME IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Anna Lukyanova, 134708

MOLECULAR AND FUNCTIONAL INTEGRITY OF CRYOPRESERVED CHRONIC MYELOID LEUKAEMIA CD34-POSITIVE HAEMATOPOIETIC STEM CELLS

EHA Library, Clare Hodkinson, 134709

COMBINED ANTICANCER ACTIVITY AND SIRNA DELIVERY BY DENGUE VIRUS CAPSID PROTEIN PEPTIDES PEPR AND PEPM AGAINST CHRONIC MYELOID LEUKEMIA

EHA Library, Ines Figueiredo, 134710

ASSOCIATION OF 3?BCR GENE DELETION WITH LACK OF MOLECULAR RESPONSE IN CML PATIENTS WITH PH-VARIANTS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Branimir Spassov, 134711

PROTEOMIC PROFILE CORRELATES TO MOLECULAR RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Nicola Sgherza, 134712

EVALUATION OF BECLIN-1 PROTEIN EXPRESSION IN CHRONIC MYELOID LEUKEMIA PATIENTS ON IMATINIB THERAPY

EHA Library, Ziad Emarah, 134713

REVERSINE TRIGGERS MITOTIC CATASTROPHE AND APOPTOSIS IN BCR-ABL POSITIVE CELLS

EHA Library, Ana Alves, 134714

COMPARISON BETWEEN AUTOMATED AND MANUAL INTERPHASE FLUORESCENT IN SITU HYBRIDIZATION (FISH) ANALYSIS OF T(9;22)(Q43;Q11.2)

EHA Library, Hend Chaker, 134715

HALVING TIME AND LOG REDUCTION ARE GOOD PREDICTORS OF OPTIMAL MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH SUB-OPTIMAL RESPONSE AT 3 MONTHS

EHA Library, Maria João Santos, 134716

EVALUATION OF CLINICAL EFFICACY AND SAFETY OF GENERIC IMATINIB IN THE TREATMENT OF CHRONIC MYELOID LEUKEMIA

EHA Library, Irena Cojbasic, 134717

PREDICTIVE FACTORS OF STABLE DEEP MOLECULAR RESPONSE IN CHRONIC PHASE CML PATIENTS TREATED WITH DASATINIB OR NILOTINIB AFTER IMATINIB FAILURE

EHA Library, Massimiliano Bonifacio, 134718

MTOR INHIBITION IN CML: A NEW THERAPEUTIC OPTION

EHA Library, Ana Bela Sarmento-Ribeiro, 134719

EFFICACY AND SAFETY EVALUATION OF NILOTINIB AND DASATINIB (2G-TKI) ON FIRST LINE TREATMENT IN 73 PATIENTS WITH CML-CP OUTSIDE OF CLINICAL TRIALS. ANDALUSIAN CML REGISTRY (RALMC).

EHA Library, José Manuel Puerta Puerta, 134720

OPTIMIZATION OF RADOTINIB DOSES BASED ON DOSE-EFFICACY AS WELL AS DOSE-SAFETY RELATIONSHIP ANALYSES FOR NEWLY DIAGNOSED PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Hayeon Noh, 134721

REAL-WORLD DATA FROM 54 BELGIAN PATIENTS FROM THE PONATINIB NAMED PATIENT PROGRAMME (NPP)

EHA Library, Timothy Devos, 134722

PREDICTORS FOR 12-MONTH MAJOR MOLECULAR RESPONSE IN CP CML PATIENTS WHO FAILED 3-MONTH EARLY MOLECULAR RESPONSE WITH IMATINIB THERAPY

EHA Library, Sung-Eun Lee, 134723

REAL-WORLD TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) IN PATIENTS WHO FAILED ≥2 PRIOR TYROSINE KINASE INHIBITORS (TKIS) AMONG US COMMUNITY ONCOLOGISTS

EHA Library, Huiqiang Huang, 134724

STEPWISE DOSE ESCALATION METHOD FOR NILOTINIB STOP TRIAL IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (STEP STOP TRIAL) : A MULTICENTER PHASE 2 TRIAL

EHA Library, Ken Ota, 134725

IMMUNOMODULATORY EFFECT OF DASATINIB THERAPY IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Maria Cioch, 134726

2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA VALIDATION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED FRONTLINE WITH 3 AVAILABLE TKIS OUTSIDE CLINICAL TRIALS

EHA Library, Massimo Breccia, 134727

COMBINATION OF HEMOGLOBIN LEVEL AT PRESENTATION WITH MOLECULAR RESPONSE AT 3 MONTHS BETTER PREDICTS SURVIVALS AND DEEP MOLECULAR RESPONSE TO IMATINIB IN CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA PATIENTS

EHA Library, Po-Shen Ko, 134728

TREATMENT, RESPONSE, AND OUTCOME IN UNSELECTED ELDERLY PATIENTS WITH NEWLY DIAGNOSED, CHRONIC PHASE (CP), PHILADELPHIA CHROMOSOME-POSITIVE (PH+) CHRONIC MYELOID LEUKEMIA

EHA Library, Gabriele Gugliotta, 134729

THYROID DYSFUNCTION CAUSED BY SECOND-GENERATION TYROSINE KINASE INHIBITORS IN PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA

EHA Library, Elena Tothova, 134730

ASSESSMENT OF THE MOLECULAR DISEASE LEVEL IN PATIENTS WITH BCR-ABL1 POSITIVE CML IN DENMARK AND ICELAND

EHA Library, Niels Pallisgaard, 134731

SAFETY AND EFFICACY OF PONATINIB IN REAL WORLD CLINICAL PRACTICE. RESULTS FROM THE SPANISH COMPASSIONATE USE PROGRAM. A GELMC STUDY

EHA Library, Valentin Garcia-Gutierrez, 134732

EARLY GOOD LATER BETTER. RELATIONSHIP OF BCR-ABL LEVEL AT 12 MONTHS OF TARGET THERAPY WITH INDIVIDUAL CHARACTERISTICS OF MOLECULAR RESPONSE IN EARLY TREATMENT PERIOD IN CHRONIC MYELOID LEUKEMIA

EHA Library, Aleksandr Fomin, 134733

EFFICACY OF GENERIC IMATINIB IN NEWLY DIAGNOSED CP-CML PATIENTS IN ESTONIAN POPULATION

EHA Library, Edward Laane, 134734

ROLE OF CHR AS A SURROGATE FOR MMR AT 12 AND 18 MONTHS IN RESOURCE CONSTRAINT SETTINGS: PATIENTS UNABLE TO AFFORD FREQUENT MOLECULAR MONITORING

EHA Library, Kamal Sahu, 134735

DEVELOPMENT OF INTERNATIONAL SCALE SECONDARY STANDARDS FOR BCR-ABL1 TRANSCRIPT QUANTITATIVE ASSAY

EHA Library, Gwo-Jen Day, 134736

LOW DOSE DASATINIB TREATMENT IN ELDERLY CML PATIENTS

EHA Library, Haruhiko Sano, 134737

A NATIONWIDE OBSERVATIONAL STUDY OF THE ISRAELI EXPERIENCE WITH PONATINIB OUTSIDE CLINICAL TRIALS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Adi Abulafia, 134738

ASSESSMENT OF PLATELET FUNCTIONS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Filiz Akbiyik, 134739

ELEVEN-YEAR RESULTS OF THE THERAPY OF CML TYROSINE KINASE INHIBITOR IN A LARGE INDUSTRIAL CENTER OF SIBERIA

EHA Library, Anna Lyamkina, 134740

CML AS PART OF DUAL MALIGNANCIES: POSSIBLE MECHANISMS AND REVIEW OF LITERATURE

EHA Library, Kamal Sahu, 134741

THE RESULTS OF TYROSINE-KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS ACCORDING TO 2013 EUROPEAN LEUKEMIANET RESPONSE CRITERIA: RUSSIAN SINGLE-CENTER STUDY

EHA Library, Oleg Shukhov, 134742

OUT OF THE BAG ? FUNCTIONAL CHARACTERIZATION OF EX VIVO EXPANDED MSC

EHA Library, Sergio Lopes, 134743

FUNCTIONAL CAPACITY OF TUMOR LYSATE-PULSED MONOCYTE-DERIVED DENDRITIC CELLS INDUCING IN VITRO IMMUNE RESPONSES

EHA Library, Catarina Pinho, 134744

CELLULAR IMMUNOTHERAPY: A STORY OF HOPE

EHA Library, Ann VAN DE VELDE, 134745

MAGIC-TT-MEDIATED CELLS TARGET TRANSPLANTATION INTO BONE MARROW WHICH INCLUDES THE STUDY OF CELL DISTRIBUTION IN VIVO AND THE EFFECTS OF HEMATOPOIETIC RECONSTRUCTION.

EHA Library, Hao Huang, 134746

IMPLICATION OF THE PERCENTAGE OF MACROPHAGES WITH HAEMOPHAGOCYTOSIS IN THE DIAGNOSIS AND PROGNOSIS OF PATIENTS WITH HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EHA Library, Teresa Knight Asorey, 134747

BIOSIMILARS OF FILGRASTIM ? ZARZIO

EHA Library, Adrian Tempescul, 134748

THE ROLE OF ENDOTHELIAL CELL-EXPRESSED ?LPHA HEMOGLOBIN AND ITS MOLECULAR CHAPERONE AHSP IN BLOOD PRESSURE REGULATION

EHA Library, Christophe Lechauve, 134749

THE 'NORMOBARIC OXYGEN PARADOX': INFLUENCE OF NEW MODELS ON THE EVOLUTION OF ERYTHROPOIETIN, RETICULOCYTE COUNT AND HEMOGLOBIN CONCENTRATION IN PATIENTS UNDERGOING BREAST RECONSTRUCTION SURGERY.

EHA Library, Rossella Calabrese, 134750

THE RELATIONSHIP BETWEEN BONE MARROW STROMAL FIBROBLASTS, MYELOGRAM PERFORMANCE AND EFFICIENCY OF CHEMOTHERAPY IN CHILDREN WITH ACUTE LEUKEMIA

EHA Library, Katherine Bruslova, 134751

APHERESIS COLLECTION OF MOBILIZED HEMATOPOIETIC STEM CELLS FROM PERIPHERAL BLOOD IN HEALTY DONORS ? 15 YEARS OF EXPERIENCE

EHA Library, Rada Grubovikj Rastvorceva, 134752

PERFORMANCE EVALUATION OF Q-FLAG OF HEMATOLOGY ANALYZER, SYSMEX XN-20

EHA Library, Hye Ryoun Kim, 134753